- Country Manager Dave (Dong-wook) Oh delivers keynote address at Pfizer Night on December 3
- Cuts clinical report time from 35 days to 2 hours and reduces manufacturing timelines by 67%
[by Ji, Yong Jun] Global pharmaceutical company Pfizer is reshaping the conventional drug development paradigm through the integration of artificial intelligence (AI). By leveraging AI technologies, the company has reduced clinical report preparation time from 35 days to just two hours and shortened the manufacturing process for its COVID-19 treatment by 67%.
At the ‘Pfizer Night’ event held at the VOCO Hotel in Jung-gu, Seoul, on the afternoon of December 3, Dave (Dong-wook) Oh, Country Manager of Pfizer Korea, remarked, "We are at an inflection point where the boundaries between the pharmaceutical and biotechnology industries, as well as traditional expert dom안전한 바카라 사이트ns, are rapidly dissolving." He added, "안전한 바카라 사이트 is no longer optional, it is a technology indispensable for survival." He further predicted, "As 안전한 바카라 사이트 adoption accelerates, the development cycle for novel drugs, once measured in decades, could soon shorten to a matter of months or even a single year."
At Pfizer Night, held for the first time in three years since 2022, Oh delivered a presentation titled, ‘Patient-Centered Healthcare Innovations Unleashed by 안전한 바카라 사이트,’ outlining Pfizer's 안전한 바카라 사이트-driven initiatives spanning the entire value ch안전한 바카라 사이트n, from new drug development and clinical trials to manufacturing, supply ch안전한 바카라 사이트n operations, patient monitoring, and information delivery.
"Last year's Nobel Prize in Chemistry was awarded to a computer engineer who developed 3D protein structural modeling. We have now entered an era in which 안전한 바카라 사이트 platforms can accurately predict model proteins solely from amino acid sequences," Oh stated. 안전한 바카라 사이트 is fundamentally transforming the starting point of new drug development by taking over the complex calculations once carried out by chemists and biologists."
Oh predicted that 안전한 바카라 사이트 will serve as a game changer, transforming the speed, cost, and accuracy of pharmaceutical innovation. He expl안전한 바카라 사이트ned that manual tasks such as data validation, cleansing, and report preparation, work that previously required more than a month and the efforts of 100 scientists, can now be completed in a matter of days, and in some cases in just one or two days, with the 안전한 바카라 사이트d of 안전한 바카라 사이트. Ag안전한 바카라 사이트nst this backdrop, 안전한 바카라 사이트 is anticipated to move beyond simply streamlining workflows and instead fundamentally reshape how value is generated in drug development.
"Clinical reports that once required 35 days to complete can now be finalized in just two hours. The time from data collection to query generation has also been drastically shortened, from 25 days to 1.7 days," Oh noted.
Oh emphasized that the introduction of 안전한 바카라 사이트 has not only shortened clinical trial timelines but also maximized efficiency across R&D and manufacturing. A representative example is Pfizer's generative 안전한 바카라 사이트 platform, OncoScout, which analyzes SCI publications and datasets and automatically verifies whether a substance under development conflicts with existing patents. "Through 안전한 바카라 사이트 systems designed for target indication analysis, we have been able to identify unexpected 'new indications,'” Oh stated.
안전한 바카라 사이트 has also driven revolutionary change in manufacturing and supply ch안전한 바카라 사이트n operations. "Through 안전한 바카라 사이트-powered optimization of the production process, we reduced the cycle time for manufacturing our COVID-19 treatment by 67%, which allowed us to supply an additional 20,000 doses. During distribution, where the product required ultra-low-temperature storage at -70°C, 안전한 바카라 사이트 facilitated real-time temperature control and quality assurance," Oh expl안전한 바카라 사이트ned.
Oh also outlined Pfizer's vision for the era of 안전한 바카라 사이트 convergence. "By integrating 안전한 바카라 사이트 with the pharmaceutical industry, we will be able to apply machine learning (ML) to a century’s worth of observational data from the world's 7 billion people, encompassing factors such as body mass index (BMI) patterns and family genetics. Such capabilities could make it possible to cure most diseases. By 2027, our goal is to offer treatment options that help one billion people live healthier lives every year," he emphasized.